BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22793037)

  • 21. Clinical characteristics and prognosis analysis of uterine sarcoma: a single-institution retrospective study.
    Wang F; Dai X; Chen H; Hu X; Wang Y
    BMC Cancer; 2022 Oct; 22(1):1050. PubMed ID: 36207687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uterine sarcomas--recent progress and future challenges.
    Seddon BM; Davda R
    Eur J Radiol; 2011 Apr; 78(1):30-40. PubMed ID: 21247711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uterine sarcoma: 14 years experience in KCCC.
    Al Wakiel H; Ragheb AM; Varghese A; Juzeer A; Vashista S; Albasmy A
    Gulf J Oncolog; 2008 Jul; (4):45-51. PubMed ID: 20084775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001.
    Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A
    Gynecol Oncol; 2008 Oct; 111(1):74-81. PubMed ID: 18657852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of patients with sarcoma of the uterus.
    Bokhman JV; Yakovleva IA; Urmanchejeva AF
    Eur J Gynaecol Oncol; 1990; 11(3):225-31. PubMed ID: 2209643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sarcomas of the uterus: a clinicopathologic study of 119 patients.
    Kahanpää KV; Wahlström T; Gröhn P; Heinonen E; Nieminen U; Widholm O
    Obstet Gynecol; 1986 Mar; 67(3):417-24. PubMed ID: 3945454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retrospective analysis of 105 cases with uterine sarcoma.
    Yoney A; Eren B; Eskici S; Salman A; Unsal M
    Bull Cancer; 2008 Mar; 95(3):E10-7. PubMed ID: 18390406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uterine sarcoma: prognostic factors and treatment evaluation.
    Naaman Y; Shveiky D; Ben-Shachar I; Shushan A; Mejia-Gomez J; Benshushan A
    Isr Med Assoc J; 2011 Feb; 13(2):76-9. PubMed ID: 21443030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of ovarian preservation in premenopausal women with stage I uterine sarcoma.
    Nasioudis D; Chapman-Davis E; Frey M; Holcomb K
    J Gynecol Oncol; 2017 Jul; 28(4):e46. PubMed ID: 28541635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnosis and therapy of uterine sarcoma].
    Viereck V; Huschmand Nia A; Pauer HU; Emons G; Krauss T
    Zentralbl Gynakol; 2002 Nov; 124(11):506-10. PubMed ID: 12796843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical outcomes of uterine sarcomas: results from 14 years worth of experience in the Kinki district in Japan (1990-2003).
    Kokawa K; Nishiyama K; Ikeuchi M; Ihara Y; Akamatsu N; Enomoto T; Ishiko O; Motoyama S; Fujii S; Umesaki N
    Int J Gynecol Cancer; 2006; 16(3):1358-63. PubMed ID: 16803530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Survival, prognostic factors and modern tendencies in adjuvant treatment of diagnosed endometrial cancer patients with or without lymph node dissection].
    Ivanov I
    Akush Ginekol (Sofiia); 2009; 48 Suppl 1():3-11. PubMed ID: 20387272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical experience with uterine sarcoma].
    Melilli GA; Di Gesù G; Loizzi V; Di Gesù A; Carriero C; Corsano P; Ferreri R
    Minerva Ginecol; 1998; 50(7-8):291-5. PubMed ID: 9808951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients.
    Bodner K; Bodner-Adler B; Obermair A; Windbichler G; Petru E; Mayerhofer S; Czerwenka K; Leodolter S; Kainz C; Mayerhofer K
    Gynecol Oncol; 2001 May; 81(2):160-5. PubMed ID: 11330943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of treatment results and prognostic factors of uterine sarcoma: A single-center experience.
    Momtahan M; Emami F; Sari Aslani F; Akbarzadeh-Jahromi M
    J Chin Med Assoc; 2020 Jan; 83(1):84-88. PubMed ID: 31517774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Epidemiological factors, treatment and prognosis of uterine sarcomas: 14 cases at the Cancer Institute of Dakar].
    Dem A; Kasse AA; Diop M; Cisse B; Toure P
    Dakar Med; 2000; 45(1):85-8. PubMed ID: 14666799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Uterine sarcomas: clinical and therapeutic aspects (10 cases)].
    Hassini A; Khemiri B; Sfar E; Chelly D; Chennoufi MB; Chelly H
    J Gynecol Obstet Biol Reprod (Paris); 2006 Jun; 35(4):348-55. PubMed ID: 16940904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uterine sarcomas: a review.
    D'Angelo E; Prat J
    Gynecol Oncol; 2010 Jan; 116(1):131-9. PubMed ID: 19853898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognoses and prognostic factors of carcinosarcoma, endometrial stromal sarcoma and uterine leiomyosarcoma: a comparison with uterine endometrial adenocarcinoma.
    Akahira J; Tokunaga H; Toyoshima M; Takano T; Nagase S; Yoshinaga K; Tase T; Wada Y; Ito K; Niikura H; Yamada H; Sato A; Sasano H; Yaegashi N
    Oncology; 2006; 71(5-6):333-40. PubMed ID: 17690557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical and pathological analysis on 106 cases with uterine sarcoma].
    Liao Q; Wang J; Han J
    Zhonghua Fu Chan Ke Za Zhi; 2001 Feb; 36(2):104-7. PubMed ID: 11783345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.